Detrimental Effects of IFN-γ on an Epidermolysis Bullosa Simplex Cell Model and Protection by a Humanized Anti–IFN-γ Monoclonal Antibody

Epidermolysis bullosa is a group of severe skin blistering disorders, which currently have no cure. The pathology of epidermolysis bullosa is recognized as having an inflammatory component, but the role of inflammation in different epidermolysis bullosa disorders is unclear. Epidermolysis bullosa si...

Full description

Bibliographic Details
Main Authors: Cedric Badowski, Tong San Tan, Teimur Aliev, David Trudil, Maria Larina, Viсtoria Argentova, Muhammad Jasrie Firdaus, Paula Benny, Vivien S.T. Woo, E. Birgitte Lane
Format: Article
Language:English
Published: Elsevier 2022-03-01
Series:JID Innovations
Online Access:http://www.sciencedirect.com/science/article/pii/S2667026722000029
_version_ 1818394170725761024
author Cedric Badowski
Tong San Tan
Teimur Aliev
David Trudil
Maria Larina
Viсtoria Argentova
Muhammad Jasrie Firdaus
Paula Benny
Vivien S.T. Woo
E. Birgitte Lane
author_facet Cedric Badowski
Tong San Tan
Teimur Aliev
David Trudil
Maria Larina
Viсtoria Argentova
Muhammad Jasrie Firdaus
Paula Benny
Vivien S.T. Woo
E. Birgitte Lane
author_sort Cedric Badowski
collection DOAJ
description Epidermolysis bullosa is a group of severe skin blistering disorders, which currently have no cure. The pathology of epidermolysis bullosa is recognized as having an inflammatory component, but the role of inflammation in different epidermolysis bullosa disorders is unclear. Epidermolysis bullosa simplex (EBS) is primarily caused by sequence variants in keratin genes; its most severe form, EBS generalized severe, is characterized by aggregates of keratin proteins, and cell models of EBS generalized severe show constitutively elevated stress. IFN-γ is a major mediator of inflammation, and we show that the addition of IFN-γ alone to disease model keratinocytes promotes keratin aggregation, decreases cell–cell junctions, delays wound closure, and reduces cell proliferation. IFN-γ exposure weakens the intercellular cohesion of monolayers on mechanical stress, with IFN-γ–treated EBS monolayers more fragmented than IFN-γ–treated wild-type monolayers. A humanized monoclonal antibody to IFN-γ neutralized the detrimental effects on keratinocytes, restoring cell proliferation, increasing cell–cell adhesion, accelerating wound closure in the presence of IFN-γ, and reducing IFN-γ–mediated keratin aggregation in EBS cells. These suggest that treatment with IFN-γ blocking antibodies may constitute a promising new therapeutic strategy for patients with EBS and may also have ameliorating effects on other inflammatory skin diseases.
first_indexed 2024-12-14T05:56:57Z
format Article
id doaj.art-1f3f8a32ff68444688d6a6207c54b3c5
institution Directory Open Access Journal
issn 2667-0267
language English
last_indexed 2024-12-14T05:56:57Z
publishDate 2022-03-01
publisher Elsevier
record_format Article
series JID Innovations
spelling doaj.art-1f3f8a32ff68444688d6a6207c54b3c52022-12-21T23:14:32ZengElsevierJID Innovations2667-02672022-03-0122100096Detrimental Effects of IFN-γ on an Epidermolysis Bullosa Simplex Cell Model and Protection by a Humanized Anti–IFN-γ Monoclonal AntibodyCedric Badowski0Tong San Tan1Teimur Aliev2David Trudil3Maria Larina4Viсtoria Argentova5Muhammad Jasrie Firdaus6Paula Benny7Vivien S.T. Woo8E. Birgitte Lane9Institute of Medical Biology, Agency for Science, Technology and Research (A∗STAR), Singapore, SingaporeInstitute of Medical Biology, Agency for Science, Technology and Research (A∗STAR), Singapore, Singapore; Skin Research Institute of Singapore (SRIS), Agency for Science, Technology and Research (A∗STAR), Singapore, SingaporeFaculty of Chemistry, Lomonosov Moscow State University, Moscow, RussiaNHDetect Corporation, Reisterstown, Maryland, USAShemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, RussiaFaculty of Biology, Lomonosov Moscow State University, Moscow, RussiaInstitute of Medical Biology, Agency for Science, Technology and Research (A∗STAR), Singapore, Singapore; Skin Research Institute of Singapore (SRIS), Agency for Science, Technology and Research (A∗STAR), Singapore, Singapore; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, SingaporeInstitute of Medical Biology, Agency for Science, Technology and Research (A∗STAR), Singapore, SingaporeInstitute of Medical Biology, Agency for Science, Technology and Research (A∗STAR), Singapore, Singapore; Department of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, SingaporeInstitute of Medical Biology, Agency for Science, Technology and Research (A∗STAR), Singapore, Singapore; Skin Research Institute of Singapore (SRIS), Agency for Science, Technology and Research (A∗STAR), Singapore, Singapore; Department of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore; Correspondence: E. Birgitte Lane, Skin Research Institute of Singapore (SRIS), Agency for Science, Technology and Research (A∗STAR), Immunos Building, 8A Biomedical Grove, Singapore 138648, Singapore.Epidermolysis bullosa is a group of severe skin blistering disorders, which currently have no cure. The pathology of epidermolysis bullosa is recognized as having an inflammatory component, but the role of inflammation in different epidermolysis bullosa disorders is unclear. Epidermolysis bullosa simplex (EBS) is primarily caused by sequence variants in keratin genes; its most severe form, EBS generalized severe, is characterized by aggregates of keratin proteins, and cell models of EBS generalized severe show constitutively elevated stress. IFN-γ is a major mediator of inflammation, and we show that the addition of IFN-γ alone to disease model keratinocytes promotes keratin aggregation, decreases cell–cell junctions, delays wound closure, and reduces cell proliferation. IFN-γ exposure weakens the intercellular cohesion of monolayers on mechanical stress, with IFN-γ–treated EBS monolayers more fragmented than IFN-γ–treated wild-type monolayers. A humanized monoclonal antibody to IFN-γ neutralized the detrimental effects on keratinocytes, restoring cell proliferation, increasing cell–cell adhesion, accelerating wound closure in the presence of IFN-γ, and reducing IFN-γ–mediated keratin aggregation in EBS cells. These suggest that treatment with IFN-γ blocking antibodies may constitute a promising new therapeutic strategy for patients with EBS and may also have ameliorating effects on other inflammatory skin diseases.http://www.sciencedirect.com/science/article/pii/S2667026722000029
spellingShingle Cedric Badowski
Tong San Tan
Teimur Aliev
David Trudil
Maria Larina
Viсtoria Argentova
Muhammad Jasrie Firdaus
Paula Benny
Vivien S.T. Woo
E. Birgitte Lane
Detrimental Effects of IFN-γ on an Epidermolysis Bullosa Simplex Cell Model and Protection by a Humanized Anti–IFN-γ Monoclonal Antibody
JID Innovations
title Detrimental Effects of IFN-γ on an Epidermolysis Bullosa Simplex Cell Model and Protection by a Humanized Anti–IFN-γ Monoclonal Antibody
title_full Detrimental Effects of IFN-γ on an Epidermolysis Bullosa Simplex Cell Model and Protection by a Humanized Anti–IFN-γ Monoclonal Antibody
title_fullStr Detrimental Effects of IFN-γ on an Epidermolysis Bullosa Simplex Cell Model and Protection by a Humanized Anti–IFN-γ Monoclonal Antibody
title_full_unstemmed Detrimental Effects of IFN-γ on an Epidermolysis Bullosa Simplex Cell Model and Protection by a Humanized Anti–IFN-γ Monoclonal Antibody
title_short Detrimental Effects of IFN-γ on an Epidermolysis Bullosa Simplex Cell Model and Protection by a Humanized Anti–IFN-γ Monoclonal Antibody
title_sort detrimental effects of ifn γ on an epidermolysis bullosa simplex cell model and protection by a humanized anti ifn γ monoclonal antibody
url http://www.sciencedirect.com/science/article/pii/S2667026722000029
work_keys_str_mv AT cedricbadowski detrimentaleffectsofifngonanepidermolysisbullosasimplexcellmodelandprotectionbyahumanizedantiifngmonoclonalantibody
AT tongsantan detrimentaleffectsofifngonanepidermolysisbullosasimplexcellmodelandprotectionbyahumanizedantiifngmonoclonalantibody
AT teimuraliev detrimentaleffectsofifngonanepidermolysisbullosasimplexcellmodelandprotectionbyahumanizedantiifngmonoclonalantibody
AT davidtrudil detrimentaleffectsofifngonanepidermolysisbullosasimplexcellmodelandprotectionbyahumanizedantiifngmonoclonalantibody
AT marialarina detrimentaleffectsofifngonanepidermolysisbullosasimplexcellmodelandprotectionbyahumanizedantiifngmonoclonalantibody
AT vistoriaargentova detrimentaleffectsofifngonanepidermolysisbullosasimplexcellmodelandprotectionbyahumanizedantiifngmonoclonalantibody
AT muhammadjasriefirdaus detrimentaleffectsofifngonanepidermolysisbullosasimplexcellmodelandprotectionbyahumanizedantiifngmonoclonalantibody
AT paulabenny detrimentaleffectsofifngonanepidermolysisbullosasimplexcellmodelandprotectionbyahumanizedantiifngmonoclonalantibody
AT vivienstwoo detrimentaleffectsofifngonanepidermolysisbullosasimplexcellmodelandprotectionbyahumanizedantiifngmonoclonalantibody
AT ebirgittelane detrimentaleffectsofifngonanepidermolysisbullosasimplexcellmodelandprotectionbyahumanizedantiifngmonoclonalantibody